Navigation Links
AMDL Announces Preliminary Third Quarter Earnings; Revises 2008 Guidance
Date:11/12/2008

TUSTIN, Calif., Nov. 12 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL), a vertically integrated pharmaceutical company with operations in China and the US, announced today preliminary third quarter earnings and revised 2008 guidance information.

For the third quarter of FY2008, AMDL expects gross sales to be approximately $12.4 million and net sales after sales promotions of approximately $9.2 million. Gross profit is expected to be approximately $4.9 million and income from operations to be approximately $2.3 million. The Company expected net income before currency translation to be approximately $1.6 million.

Earnings were originally projected to be approximately $3.4 million. However, the Company made a strategic decision to offer promotional discounts of $3.2 million to promote new product sales in the Chinese marketplace, primarily for the newly released formulations of AMDL's best-selling Goodnak(R) anti-aging product line. The existing promotional discounts will carry forward into the fourth quarter of 2008 and the first quarter of 2009. Based upon this information, AMDL continues to anticipate targeted gross sales of approximately $32 to $36 million for 2008. With regards to earnings guidance, the Company now estimates net income before foreign currency translation to be between $1.8 and $ 2.2 million for FY2008.

"We're operating AMDL for long-term success in a period of accelerated growth," said AMDL's Chairman and newly appointed CEO Mr. Douglas MacLellan. "We made a strategic and conscious decision to provide sales promotion discounts for certain new products in the third and fourth quarters which we believe will accelerate the introduction and market penetration. Specifically, sales promotion discounts incurred this quarter are the result of a promotion campaign to expand AMDL's sales footprint for newly released formulation of our Goodnak anti-aging line -- AMDL's highest profit margin product line. This is an investment an
'/>"/>

SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Metabolex Announces Positive Results From Phase 1a Clinical Trial of MBX-2982
2. Standard & Poors Announces Changes to U.S. Indices
3. Quanterix Corporation Announces the Addition of Dr. Robert Corn to its Scientific Advisory Board
4. Cardiums InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
5. Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
6. China Biologic Products Announces Third Quarter 2008 Results Conference Call
7. Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA Meeting
8. Heritage Labs Announces A1c Test Certification Milestone
9. Nventa Biopharmaceuticals Announces Third Quarter 2008 Financial Results and Recent Corporate Highlights
10. The Binding Site Announces Trading Update for Year Ended September 30th 2008
11. CorMatrix Announces Pre-Clinical Data Suggesting Next Generation ECM Technology(TM) Can Improve Cardiac Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... A challenge donation from the Bezos family ... total to more than $7 million for Fred Hutchinson ... of the live auction during which guests raise their ... million to be directed toward the Hutchinson Center,s work ... ,, The black-tie Gala took place Dec. 5 ...
(Date:12/4/2009)... NEW YORK, Dec. 4 Stemline Therapeutics, Inc. today announced ... SL-401 and SL-501, in both in vitro and ... selected for poster presentation at the upcoming 51st Annual Meeting ... in New Orleans from December 5-8, 2009. The poster will ...
(Date:12/3/2009)... Inc. (Nasdaq: VIAP ), a biotechnology company focused ... cardiovascular and metabolic disease, today announced that it has ... FDG-PET clinical trial of VIA-2291. ,, The FDG-PET ... five sites in the US and Canada including Massachusetts ...
(Date:12/3/2009)... Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at ... spoke at a conference on High-Risk Diabetic,Foot Care ... is China,s leading,stem cell research and regenerative medicine ... organized by the Indian Podiatry Association (IPA), aimed,to ...
Breaking Biology Technology:34th Annual Hutch Holiday Gala Raises More Than $7 Million For Cancer Research 234th Annual Hutch Holiday Gala Raises More Than $7 Million For Cancer Research 3Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
... ADR Listing to the NASDAQ Capital Market, ... XTLB ; LSE: XTL; TASE: XTL), a ... of,therapeutics for the treatment of unmet medical needs, ... receipt on August 23,2007, of a NASDAQ Staff ...
... ARUP Laboratories, a national,clinical and anatomic pathology reference ... development, announced today that it has,renewed a multisource ... of the nation,s largest purchasing alliances of leading,hospitals ... previous,contract between ARUP and Premier which has been ...
... Aug. 27 Globus Medical, Inc., the largest,privately held ... for the quarter ending June 30, 2007. The company ... an increase of 52% over,the $19.9 million it achieved ... on the heels of $110 million in series E ...
Other Biology Technology:XTL Receives Staff Letter From NASDAQ 2XTL Receives Staff Letter From NASDAQ 3ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services 2Globus Medical Announces Record 2nd Quarter 2007 Results 2
(Date:12/3/2009)... his co-workers discovered that specific types of human papillomavirus ... these pathogens cause cells to degenerate. It is known ... and E7. Both proteins switch off different cellular control ... Frank Rsl and his co-workers at DKFZ have now ...
(Date:12/3/2009)... animal species can be likened to emptying a museum of ... into the trash, or replacing every local cuisine with McDonald,s ... may not just make the world boring. New research now ... catching some nasty disease. , "Habitat destruction and biodiversity loss,"driven ...
(Date:12/3/2009)... message: , , Preliminary Press Conference Topics, ... of Sciences museum, Attention PIOs: Sending Press Releases ... deadline 10 December, News Media registration information , ... 7 December, Who,s coming, , For important ...
Breaking Biology News(10 mins):Papillomavirus silences innate immune response 2Species down, disease up 2Species down, disease up 3Species down, disease up 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6Doctor Pharmacist Teams Boost Blood Pressure Control 61978 1Doctor Pharmacist Teams Boost Blood Pressure Control 61978 2Doctor Pharmacist Teams Boost Blood Pressure Control 61978 3 Vioxx Problems Known Years Before Recall 61976 1 Vioxx Problems Known Years Before Recall 61976 2 Vioxx Problems Known Years Before Recall 61976 3 Vioxx Problems Known Years Before Recall 61976 4Hazelden Names Leadership Team for New Recovery Center in Naples Florida 61974 1Hazelden Names Leadership Team for New Recovery Center in Naples Florida 61974 2
... Biotechnology: Economics and Policy, edited by Richard ... has won the Quality of Communication Award from ... recognizes publications that demonstrate superior communication of concepts ... Agricultural Biotechnology: Economics and Policy assembles 33 ...
... barcoding experts from 46 nations will converge in ... agencies and others beginning to realize potential applications ... protection and food safety to disease prevention and ... scientific field could, among many other things, help ...
... 2007 winner of the ALPSP/Charlesworth Award for Publishing Innovation. ... innovative approach to any aspect of scholarly publication, the ... was RSC Project Prospect from the Royal Society of ... chemical science publishing. RSC Project Prospect journals incorporate standard ...
Other Biology News:Amid spiralling government interest, world's top 350 DNA barcode scientists meet in Taipei 2Amid spiralling government interest, world's top 350 DNA barcode scientists meet in Taipei 3Amid spiralling government interest, world's top 350 DNA barcode scientists meet in Taipei 4Amid spiralling government interest, world's top 350 DNA barcode scientists meet in Taipei 5Amid spiralling government interest, world's top 350 DNA barcode scientists meet in Taipei 6Amid spiralling government interest, world's top 350 DNA barcode scientists meet in Taipei 7Amid spiralling government interest, world's top 350 DNA barcode scientists meet in Taipei 8RSC Project Prospect scoops prestigious award 2
... polyclonal to HDAC4 - ChIP Grade ... II mammalian histone deacetylases, which consists of ... is highly similar to the deacetylase domain ... shuttles between the nucleus and cytoplasm in ...
Our Histology, Immunohistochemistry and tissue arrays services include samples processing, different type of staning, histollogical stains, image analysis, tissue arrays, immunohistochemistry, etc....
Mouse monoclonal antibody raised against a partial recombinant FBXO24. NCBI Entrez Gene ID = FBXO24...
...
Biology Products: